Dong-A's DA-8159 wins KIPO's patent award

Published: 2003-10-22 06:57:00

Updated: 2003-10-22 06:57:00

Dong-A Pharm said its novel pyrazolopyrimidine derivative (DA-8159), an impotence medication, recently won Chi Seok-yong Award in the third quarter of this year from the Korean Intellectual Property Office.

DA-8159 has less side effects than other conventional compounds in terms of headache an...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK